Coming this week...
A major challenge facing the #CGT community is understanding how to adequately support phase-appropriate readiness of analytical assays used in all phases of clinical development on the pathway towards regulatory filing.
The BioPhorum #ATMP Phase Appropriate Approach to Assay Validation workstream have generated a presentation consolidating opinions and recommendations with an aim to promote alignment on a common phase-appropriate approach to analytical assay development in some of the most common CGT modalities.
The goal of the collaboration is to provide a faster, more efficient development route that is compliant with regulatory standards.
Thank you to all who have contributed to this important discussion:
Jenny Kim, R. Alan Llenado, Ph.D., Aparna Subramanian, Ph.D, Manjula Aysola, Kieron McIntyre, santoshkumar khatwani, Ying Li, PING CARLSON, Nasser Sadr, Katie Holton, Jeanette Young Astellas Pharma US, Dominic Hildebrand, Zhu Pirot Bayer, Jason Matthews, Stuart Beattie, Douglas Brown, Silke Wissing, Berangere Tissot, Srividya Ramanathan, Weihong Wang, Kamran Abbas, Dengyun (Daisy) Sun, Yan Zhao, Roland Pach, Michael Molony, Shashi Prajapati (Ph.D) and Anne-Sophie Cottard
Sarah Currie, PMP, Steven Wall, Christine Boswell, Kathleen O’Hagan, Rachel Hodges, Evelyn Camon, Simon Walker
#CAR-T #AAV #phaseappropriate #assayvalidation
Senior consultant USP-797,800, SME for FDA
1moCongratulations, let me know if I could be of assistance ever.